HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A X Zhu Selected Research

A X Zhu Research Topics

Disease

5Neoplasms (Cancer)
01/2019 - 07/2007
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 07/2007
2Hypertension (High Blood Pressure)
12/2017 - 04/2013
2Adenocarcinoma
07/2014 - 06/2011
2Neutropenia
04/2013 - 03/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Hemorrhage
12/2017
1Proteinuria
12/2017
1Ischemia
09/2014
1Reperfusion Injury
09/2014
1Hypoxia (Hypoxemia)
09/2014
1Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2014
1Gallbladder Neoplasms (Gallbladder Cancer)
07/2014
1Rectal Neoplasms (Rectal Cancer)
01/2014
1Pathologic Complete Response
01/2014
1Stroke (Strokes)
04/2013
1Lymphopenia (Lymphocytopenia)
04/2013
1Pulmonary Embolism
04/2013
1Thrombocytopenia (Thrombopenia)
04/2013
1Carcinoma (Carcinomatosis)
06/2011
1Hepatitis
09/2010
1Infections
09/2010
1Fibrosis (Cirrhosis)
09/2010
1Nausea
03/2009
1Anorexia
03/2009
1Thrombosis (Thrombus)
03/2009
1Fatigue
03/2009
1Embolism (Embolus)
03/2009
1Diarrhea
03/2009

Drug/Important Bio-Agent (IBA)

3Fluorouracil (Carac)FDA LinkGeneric
01/2014 - 07/2007
2Monoclonal AntibodiesIBA
12/2017 - 06/2011
2Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2014 - 07/2007
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2014 - 07/2007
2Bevacizumab (Avastin)FDA Link
01/2014 - 07/2007
2ErbB Receptors (EGF Receptor)IBA
06/2011 - 07/2007
1CateninsIBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1HydrocarbonsIBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1RamucirumabIBA
12/2017
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2017
1Angiogenesis InhibitorsIBA
12/2017
1Immunoglobulins (Immunoglobulin)IBA
12/2017
1salicylhydroxamic acid (SHAM)IBA
09/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014
1PlatinumIBA
07/2014
1GemcitabineFDA Link
07/2014
1Panitumumab (Vectibix)FDA Link
07/2014
1Uric Acid (Urate)IBA
04/2013
1Cetuximab (Erbitux)FDA Link
06/2011
1Tyrosine Kinase InhibitorsIBA
06/2011
1AflatoxinsIBA
09/2010
1Cisplatin (Platino)FDA LinkGeneric
03/2009
1Docetaxel (Taxotere)FDA Link
03/2009
1Irinotecan (Camptosar)FDA LinkGeneric
03/2009
1Leucovorin (Folinic Acid)FDA Link
07/2007
1MAC321IBA
07/2007
1Paclitaxel (Taxol)FDA LinkGeneric
07/2007

Therapy/Procedure

6Therapeutics
01/2019 - 07/2007
1Ischemic Postconditioning
09/2014
1Radiotherapy
01/2014